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Airway remodelling is a well-established feature in asthma and chronic obstructive lung disease (COPD), secondary to chronic
airway inﬂammation. The structural changes found on pathological examination of remodelled airway wall have been shown to
displaysimilaritiesbutalsodiﬀerences.Computedtomography(CT)istodayaremarkabletooltoassessairwaywallmorphologyin
vivosince submillimetric acquisitions over the whole lung volume could be obtained allowing 3D evaluation. Recently, CT-derived
indices extracted fromCTimages have been described and are thought toassess airway remodelling. This may help understandthe
complex mechanism underlying the remodelling process, which is still not fully understood. This paper summarizes the various
methods described to quantify airway remodelling in asthma and COPD using CT, and similarities and diﬀerences between both
diseases will be emphasized.
1.Introduction
Asthma and COPD are the most prominent obstructive lung
diseases and aﬀect millions of people with an increasing
incidence. In their purest form, both clinical presentations
are diﬀerent [1]. Asthma is a youthful onset in nonsmokers,
related with episodic and reversible airway obstruction in
response to a stimulus. Conversely COPD is characterized
by tobacco-related airﬂow obstruction, which is progressive
and poorly reversible [2]. Airway remodelling is a well-
established structural feature observed in both diseases,
though to be the consequence of chronic airway inﬂam-
mation. The complex mechanism underlying this process is
not fully understood [3]. Pathologically, airway remodelling
consists in structural changes within the airway wall, such as
anincreasedepitheliumbasalmembranousthickness,hyper-
trophy of the smooth muscle cell, and peribronchial ﬁbrosis.
Despite similarities, the remodelling features found in both
diseases are diﬀerent [4]. The epithelium appears to be more
fragile in asthma, and the epithelial membrane thickness
and the bronchial smooth muscle are thicker than in COPD.
In severe cortico-dependent asthma, the bronchial wall
remodelling involves a neoangiogenesis process. In COPD,
epithelium displays mucous metaplasia, and inﬂammation
is associated with loss of alveolar attachments, surrounded
by peribronchial ﬁbrosis. Conversely, emphysema is the
hallmark of severe COPD, which involves also destruction
of alveolar walls. Computed tomography (CT) appears to
be an eﬀective and sensitive noninvasive tool to investigate
morphological changes of the lung and bronchi in vivo
[5, 6]. The whole volumeof the lung can be evaluated by
submillimetric acquisition allowing 3D reconstructions, and
fully automatic quantiﬁcation measurements are achievable
using dedicated software. CT-derived indices have been
deﬁned and proposed as useful tool for evaluating airway
wall remodelling [7, 8]. This literature review summarizes
the methods developed to assess airway remodelling, their
ﬁndings, and discuss the similarities or diﬀerences found
between asthma and COPD using CT.2 Pulmonary Medicine
2.QuantitativeCTofLarge-to-
Intermediate Airways
2.1. Quantitative CT Applied to Airway Wall
2.1.1. Quantiﬁcation of Airway Wall Thickness. Airway wall
thickness is a nonspeciﬁc feature and a subjective visual
ﬁnding increased in most obstructive lung diseases. CT
methods have been developed to measure and improve the
reproducibilityofthisassessment.Pathologically,airwaywall
thickness can be related to structural changes of remod-
elling but also to oedema and inﬁltration of inﬂammatory
cells [3]. Therefore, before CT scanning, a suﬃcient anti-
inﬂammatory treatment is recommended when the objective
is to assess structural changes reﬂecting remodelling features
[9, 10].
Conductive airways larger than 1mm in diameter are
clearly visible on CT scans, and CT-derived methods for
measurement of their wall dimensions have been developed.
The rationale is to segment the airway intraluminal area
(LA) and the total bronchial area (WT). Then the wall area
(WA) corresponds to the diﬀerence WA = WT – LA. WA%
represents WA normalised on WT, that is, WA% = (WA/WT)
× 100. WA and LA are not independent from body height,
and they should be normalised on body surface area (BSA),
to reduce interindividual variability.
Variousmethodshavebeenreportedtoextractthesedata
from CT images. A manual method has been ﬁrst described
and consists in tracing the one-dimensional internal (L)
and external (D) bronchial wall (Figure 1(b)). After D and
L measurements, the wall thickness indices are calculated
with the assumption that the bronchial external and internal
perimeters are perfectly round shaped, and the bronchial
wall thickness is constant around the cross-section [11–
13]. However, bronchial contours may present irregularities,
especially on diseased bronchi, and the remodelling pro-
cess is not circumferentially homogeneous all around the
bronchial wall. Therefore, the manual method may yield
measurement biases.
To take into account the shape variability of bronchial
walls, authors have proposed tracing manually on CT
images the whole external and internal wall perimeters [14].
An extrapolation should be performed when the external
wall abuts a vessel (Figure 1(c)). Owing to its geometry
nearly perpendicular to the axial plane, the right apical
bronchus (RB1) has been the most frequently studied [15].
Nevertheless, manual methods are time consuming, and
exposed to intra- and interobserver variability and prone to
parallax errors when the reconstructed plane is not strictly
perpendicular to the measured bronchi.
Semiautomatic computational methods have been later
developed to allow more reliable and reproducible quantiﬁ-
cation.Computationalalgorithmshavebeenimplementedto
segment the airway wall contours and calculate airway wall
dimensions [16]. The mostly employed have been the full-
width-at-half-maximum (FWHM) method (Figure 2). The
principle is given by the diﬀerence between the two extreme
values at which the wall attenuation is equal to half to its
maximum [17, 18]. Other methods have been proposed, and
they all tend to minimize intra- and interobserver variability
of wall thickness measurements. Though they have proven
not to be interchangeable in longitudinal studies, there is still
no consensus about which one is the best suitable to be used.
2.1.2.QuantiﬁcationofAirwayWallAttenuation. Airwaywall
densityistheresultoftheX-Rayattenuationbythebronchial
wall components. The information provided diﬀers from
the wall thickness since it is mainly related to the tissular
components present into the airway wall. For instance a thin
calciﬁed bronchus may have a higher attenuation than a
thick noncalciﬁed other one. The use of this index has been
recently emphasized.
In a murine model of asthma, Lederlin et al. [19] studied
the peribronchial attenuation (PBA) using micro CT with a
spatial resolution of 46 microns. They described a manual
method to segment the peribronchial space and measure the
wall attenuation within a circumferential region of interest
arbitrary equal to the radius of the target bronchi. In COPD
patients, Washko et al. [17] and Yamashiro et al. [18] studied
the peak wall attenuation (PWA) value. To understand this
new biomarker, its value is extracted from bronchial wall
single intensity curves, radiating outward from the centroid
of the airway lumen (Figure 2). This new approach tends to
bettercharacterizetheairwaywallcomponentsthroughtheir
globalattenuationonCTimages.However,bothmanualand
semiautomatic methods using the FWHM principle are not
completely independent from airway wall thickness [18].
2.1.3. Bronchial Tree Segmentation. The bronchial tree can
be extracted from CT acquisitions using dedicated software
[20, 21]. The seeded region-growing algorithm (Figure 2)
consists in a segmentation of the bronchial lumen using
a bithresholding. A point is placed manually within the
trachea, and voxels connected to the seed point are recruited.
The skeleton of the bronchial volume is then computed,
allowing perpendicular planes across the targeted bronchi
to be acquired. WA indices are automatically extracted. The
three-dimensional geometry of the bronchial tree can be
visualised, and this is relevant knowing the heterogeneity
of alterations in asthma. However, the bronchial human
tree displays a mean of 24 divisions including the trachea,
and only 10 divisions are reasonably achievable using this
method. In COPD, the presence of emphysema areas doesn’t
allow the seeded region-growing algorithm to discriminate
airway lumen from lung parenchyma beyond the segmental
or lobar level [22].
2.2. Airway Wall Remodelling in Asthma and COPD
Using Quantitative CT. In asthma, the remodelling process
involves the whole bronchial tree, from large to small con-
ductive airways [4]. From in vivo biopsies, the bronchial wall
thickness, measured using CT, have been shown to correlate
with remodelling features on pathological examinations.
Strong correlations have been found between the WA/LA
indices and the epithelial and lamina reticularis thickness
[23], the smooth muscle area, and the inﬁltration of the
smooth muscle by mast cells [24]. Correlations of increasedPulmonary Medicine 3
Figure 1: Top left. Thin section CT image, perpendicular to the fourth generation of the right apical bronchus from a random patient. Top
right. Sample of manual airway wall thickness extraction. Green doublehead arrow indicates external diameter D, and red doublehead arrow
shows internal diameter L. Bottom left. Sample of manual delineation of the external layer (green line) and internal layer (red line), using





























attenuation variation along the blue arrow seen in right image.
wall thickness with function tests have also been studied, but
the results are controversial. For example, since increased
smooth muscle cell layer is a condition to develop airway
hyperreactivity(AHR)inasthma,correlationsbetweenAHR
and increased wall thickness of bronchi would be expected.
However,usingWA%indices,eitherpositive[25]ornegati v e
correlations [26] have been described with AHR. Therefore,
another theory has emerged, indicating that remodelled and
thickened asthmatic airways are less distensible and may
explain chronic airway obstruction [26]. Considering intra-
luminal area measurements, LA indices may indicate either
bronchial dilation [27], or bronchial narrowing [24, 28],4 Pulmonary Medicine
or no diﬀerence [23, 29] in asthmatic subjects when com-
pared with control. These apparently conﬂicting results have
been attributed to the known heterogeneity of bronchial
involvement in asthma. Very few data are available so far
concerning airway wall attenuation. In a murine model of
asthma, the peribronchial attenuation has been shown to
relatewithbothinﬂammationandremodellingfeatures[19].
In COPD, in vivo invasive measurements and ex vivo
studies of airway resistance have revealed that distal airways
are the main site of airﬂow obstruction in COPD. Using CT,
the wall of the small airways <1mm diameter is beyond the
spatial resolution of the technique and cannot be visualized.
However large and intermediate airways are not free of
abnormalities [30]. The WA indices are increased in COPD
smokers, and these dimensions are larger than in smokers
without COPD or nonsmokers [31]. Moreover, it has been
shown that the mean dimensions of airways with an internal
perimeter greater than 7.5mm are predictive of the mean
dimensions of small airways with an internal diameter
of 1.25mm [32]. In COPD patients, correlations were
found between WA and LA indices measured by CT with
lung obstructive indices measured with PFT, such as FEV1
predicted, forced vital capacity (FVC), residual volume/total
lung capacity (RV/TLC), and FEF25%–75% [33]a sw e l la s
with DLCO [34]. The bronchial wall attenuation measure-
ment has also been assessed in COPD patients. Using the
FWHMalgorithm,thepeakwallattenuationofthebronchial
wall was found to correlate with airway obstruction assessed
by PFT [17, 18].
To the best of our knowledge, few studies have directly
comparedairwaywallremodellingusingCTbetweenasthma
and COPD, and results are not the same. Data around WA
indices indicate either no diﬀerence [12, 13], or a larger
airway wall thickness in asthmatic patients, thought to be
consistent with an increased smooth muscle mass [35].
These apparently conﬂicting results seem to underly the
fact that results around WA indices and correlation with
PFTs are not free from variability. This heterogeneity can be
partially explained by the lack of consensus regarding patient
characteristics and method of WA% quantiﬁcation. Taken
together, studied populations were heterogeneous from one
study to another, and either manual or automatic methods
of quantiﬁcation have been used. Regarding the known
heterogeneity of bronchial involvement in airway diseases, it
could appear critical to know whether a random selection of
bronchi [12, 13], a single bronchi measurement as reported
onRB1[15],oranexhaustivequantiﬁcationofthemoverthe
whole bronchi tree is needed to match perfectly the disease
reality. Correlations were reported with PFTs, but no patho-
logic data have been performed to assess any correlation
with structural changes in that comparison purpose. Since
WA% is aspeciﬁc from airway wall components, the smooth
muscle mass consistency in asthma [1, 4] could theoretically
be balanced with the peribronchial ﬁbrosis displayed in
COPD [3]. Hence it remains unclear whether CT can help
discriminate between asthma or COPD conditions using
WA% quantiﬁcation, and further assessment is still to be
performed to allow it, or not, as a robust standard for a
clinical routine practice.
3.QuantitativeCTofSmallAirway
3.1. Methods of Quantitative CT Applied to Small Airways
3.1.1. Quantiﬁcation of Emphysema. Small conductive and
distal airways are beyond the spatial resolution of CT in
humans. However, the lung parenchyma density, measured
on CT scans in Hounsﬁeld Units (HU), results from the X-
ray attenuation by intralobular structures, such as alveolar
membranes, interstitium, capillaries, or small conductive
airways. Therefore, any change in either of them is able to
modify the lung attenuation values, and this provides an
indirect tool to assess distal airway remodelling. Emphysema
is deﬁned as areas of alveolar membrane destruction and loss
of the lung elastic recoil around the small bronchi and is
a component of airway remodelling seen in severe COPD.
Two quantitative methods have been developed [36, 37]. The
densitymaskmethodconsistsinapplyingadensitythreshold
within the lung ﬁeld to count low-density lung voxels. Then,
the density mask technique is deﬁned as the percentage
LAA% of total lung volume that contains voxels of lower
attenuation than a predeﬁned threshold, usually −950HU
[36]. The percentile method [37] is based on predeﬁned
percentages (1%, 5%, or 15%) at which voxels have lower
attenuation values. Semiautomatic softwares are available to
extract areas of contiguous voxels containing the same lung
attenuation values and allow fast and accurate quantiﬁcation
of areas thought to represent emphysematous changes.
Nevertheless, limitations have been reported. A paradox-
ical fall in lung density has been reported after smoking
cessation, mimicking rapid progression of emphysema in
COPD smokers [38]. In that case the lower lung attenuation
values have been addressed to an anti-inﬂammatory eﬀect
of smoking cessation which is not to be misinterpreted. Age
and lung volume involve density variations too, but not sex
gender [39]. Interestingly, attenuation values are modiﬁed
after contrast application. Therefore, nonenhanced CT scan
is to be the reference [40].
Semiautomatic softwares are available to extract areas
of contiguous voxels containing the same lung attenuation
values and allow fast and accurate quantiﬁcation of areas
thought to represent emphysematous changes (Figure 3).
3.1.2. Quantiﬁcation of Small Airway Obstruction. Airﬂow
limitation induced by small airway obstruction is deﬁned as
the air-trapping phenomenon. Physiologically, air trapping
is an abnormal retention of air in the lungs observed in
obstructive lung diseases after expiration. The result is an
elevatedresidualvolumeseenonPFT.Onend-expiratoryCT
scans, the retention of air involves areas of low lung density
compared with normal areas of higher value. Nevertheless,
low-density areas are not speciﬁc for air trapping since
emphysema and local hypoperfusion of lung tissue may have
the same eﬀect. Various methods have been reported for
air-trapping measurement using CT, from visual grading
[41] to manual counting [42]. A Semiautomatic method
of quantiﬁcation has been reported using the density mask
technique. CT scans performed at forced residual capacity
(FRC) showed that the intralobar density value has a meanPulmonary Medicine 5
Figure 3: Segmented axial thin section image of right and left lung,
from which the mediastinum and lung contours were removed.
Usingthedensitytechnique,darkblueareasindicatevoxelsbetween
−1000 HU and −950 HU.
of −8 5 6 H U .H e n c e ,av o x e li n d e xo f−850 UH on end-
expiratory scans has been thought to represent air trapping,
whether the lung volume involved is more than 9.66% of the
total lung volume [43]. However, there is today no consensus
about which one is the best method suitable to be used,
and the delineation of a threshold as a cut-oﬀ value between
trappers and nontrappers is still in process.
3.1.3. Small Airway Remodelling in Asthma and COPD Using
Quantitative CT. In asthma, CT lung parenchyma changes
have been reported. Laurent et al. [41] showed that the
mosaic perfusion pattern was signiﬁcantly increased at full
inspiration in asthmatic subjects, and that this result was
addressed to either hypoxic vasoconstriction or small airway
obstruction.Theyalsofoundthattheairtrappingphenotype
was increased in asthmatic and healthy smokers, but not in
controls.Inasthmaticpatients,air-trappingscorescorrelated
with small airway obstruction, assessed by FEV1 and FEF25–
75%, which is consistent with small distal airway alterations.
Moreover, the focal and diﬀuse air trapping (E/I ratio) have
been shown to correlate with airway wall thickness (WA%)
[42]. This should indicate that the remodelling process
involves both proximal and distal airways in asthma.
In COPD, correlations between the extent of emphysema
and pulmonary function tests have been well established.
LAA% has been shown to correlate with FVC% predicted,
FEV1% predicted, FEV1/FVC, RV/TLC, and DLCO/VA [44–
50]. However, the major interest of CT should not be
to replace PFTs, but to allow quantiﬁcation of structural
modiﬁcations and disease phenotypes based on CT imaging.
A distribution predominantly in the lower lobe zones has
been shown to correlate with obstructive dysfunction and
DLCO [51]. Moreover, LAA% has been shown to be a
predictor of lung function decline in smokers with normal
PFT [52–54], and correlations were found with clinical
outcomes [55–57]. A multivariate analysis comparing age,
PFT, BMI, and emphysema assessed by CT revealed that
LAA% had the strongest association with mortality [58].
However, a large amount of overlap exists in clinical
practice between asthma and COPD [1, 2]. In a multivariate
analysis, Busacker et al. [43] studied a series of asthmatic
patients displaying the air-trapping phenotype on their end-
expiratory CT scans. The results showed that these patients
are more likely to have a history of pneumonia, neutrophilic
inﬂammation, and atopy. Since neutrophilic inﬂammation is
consistent with a Th1-mediated immune response, and not
a Th2-mediated as usually seen in asthma, this result should
partly explain why an overlap can exist in a clinical practice.
Patients are indeed prone to develop in vivo both immune
responses when they are exposed to various exogenous
agents.
Moreover, both obstruction of the small conductive air-
ways and loss of alveolar attachments are related with desta-
bilisation and premature airway closure during expiration.
Therefore, it could be diﬃcult to diﬀerentiate emphysema,
usually not seen in asthma, from air trapping on CT scans,
which can be seen in both diseases. Nevertheless, Matsuoka
et al. [59] have reported a quantitative method in order to
try diﬀerentiating between these two disease conditions. In
COPD patients displaying emphysema, they excluded voxels
below −950HU as a validated surrogate of emphysema areas
onCTscans.Afterthisﬁrststep,theyshowedthattherelative
change in lung density between inspiratory and expiratory
CT scan had a strong correlation with FEV1, FEF25%–75%,
and RV/TLC, using a threshold measured at −860HU. They
concluded that their method is helpful to discriminate air
trapping from emphysema in COPD patients.
4.Perspectives
CT is of major interest when assessing asthma and COPD in
vivo. Data coming from histological studies have shown that
these two diseases are diﬀerent regarding their clinical, but
also morphological and structural features. However, CT is
a monocontrast technique, and there is a lack of speciﬁcity,
which needs to be addressed. Wall thickness or nonenhanced
wall attenuation doesnot allow discriminating between the
various airway wall components, and lung attenuation may
bealteredbyanychangeinintralobularstructures.Hencethe
reported histological diﬀerences between asthma and COPD
are hard to be transposed to CT.
To allow a better understanding and comparison of these
twodiseasesusingCT,spatialresolutionshouldbeimproved.
Blurring eﬀect alters CT wall thickness quantiﬁcation of
small-to-intermediate airways inferior to 1mm. This is
relevant, knowing the fact that small airways are the main
site of disease in COPD.
Wall density is a new biomarker in asthma and COPD,
which attempts to reﬂect the wall composition instead of the
disease extension given by wall thickness. However, no data
exists about CT-enhanced wall attenuation value changes
using a contrast medium. For instance a hypothetical
peribronchial ﬁbrosis enhancement in COPD or chronic
asthma should be expected. Speciﬁc contrast medium,6 Pulmonary Medicine
targeting peribronchial smooth muscle or ﬁbrosis, should be
developed.
MRI techniques using noble hyperpolarized gases have
been reported and provide good correlation with CT quan-
tiﬁcations. It allows high quality images of ventilation and
provides functional information on ventilation cartography
or gas diﬀusion. However, they are cost eﬀective, and their
use is still conﬁdential.
5. Concluding Remarks
By measuring changes in airway wall and the amount of
air trapping, CT may help clarifying the complex phys-
iopathology underlying asthma and COPD and evaluating
the eﬀect of treatments. However, CT-derived indices are
nonspeciﬁc since both inﬂammation and remodelling may
lead to similar changes. Then clinical status and previous
use of treatments should be known when interpreting CT
changes in these patients. Further developments are suitable;
spatial resolution should be improved to prevent blurring
of the wall contours; a better delineation of the airway
wall contours is needed. Finally the multiplicity of factors
of variability in CT measurements should lead to rigorous
methods of CT technique. Therefore, the use of quantitative
CT is today a research tool and not a daily routine test.
Abbreviations
COPD: Chronic obstructive pulmonary disease
CT: Computed tomography
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WT: Total bronchial area
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FVC: Forced vital capacity
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TLC: Total lung volume
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